LAMP1 antibody (Lysosomal-Associated Membrane Protein 1) Primary Antibody
- Human, Mouse, Non-Human Primate
- This LAMP1 antibody is un-conjugated
- Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
- The mouse monoclonal antibody H4A3 recognizes CD107a, an approximately 100-120 kDa glycoprotein expressed mainly on lysosomal, but also on the plasma membrane.
- Cross-Reactivity (Details)
- Human, Non-Human Primates, Mouse
- Purified by protein-A affinity chromatography
- > 95 % (by SDS-PAGE)
- 0.2 μm filtered
- Human PBMC
anti-Lysosomal-Associated Membrane Protein 1 (LAMP1) (AA 301-417) antibody Primary Antibody
LAMP1 Reactivity: Human, Mouse, Rat, Monkey ELISA, FACS, ICC, IF (cc), IF (p), IHC (fro), IHC (p), WB Host: Rabbit Polyclonal unconjugatedanti-Lysosomal-Associated Membrane Protein 1 (LAMP1) (AA 1-382), (Extracellular Domain) antibody Primary Antibody
LAMP1 Reactivity: Human ELISA, ELISA (Detection), FACS, IF, IF/ICC, IHC (p), IP, WB Host: Mouse Monoclonal 07 unconjugatedanti-Lysosomal-Associated Membrane Protein 1 (LAMP1) (AA 1-382), (Extracellular Domain) antibody Primary Antibody
LAMP1 Reactivity: Human ELISA, FACS, IF, IF/ICC, IHC (p), IP, WB Host: Rabbit Monoclonal 107 unconjugatedanti-Lysosomal-Associated Membrane Protein 1 (LAMP1) antibody (APC) Primary Antibody
LAMP1 Reactivity: Human, Mouse, Non-Human Primate FACS, ICC, IHC (fro), IHC (p), WB Host: Mouse Monoclonal H4A3 APC
- Application Notes
- Optimal working dilution should be determined by the investigator.
- For Research Use only
- 1 mg/mL
- Azide free phosphate buffered saline (PBS), approx. pH 7.4, 0.2 μ,m filter sterilized.
- Azide free
- Handling Advice
- Do not freeze.
- 4 °C
- Storage Comment
- Store at 2-8°C. Do not freeze. Do not use after expiration date stamped on vial label.
Majer, Vlaskova, Krol, Kalina, Kubanek, Stolnaya, Dvorakova, Elleder, Sikora: "Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency." in: Gene, Vol. 498, Issue 2, pp. 183-95, 2012 (PubMed).
Mao, Tu, Liu, Qin, Zheng, Chan, Lam, Peiris, Lau: "Inhibition of human natural killer cell activity by influenza virions and hemagglutinin." in: Journal of virology, Vol. 84, Issue 9, pp. 4148-57, 2010 (PubMed).
Yu, Gallegos, Marches, Zurawski, Ramilo, García-Sastre, Banchereau, Palucka: "Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines." in: Blood, Vol. 112, Issue 9, pp. 3671-8, 2008 (PubMed).
Carlsten, Björkström, Norell, Bryceson, van Hall, Baumann, Hanson, Schedvins, Kiessling, Ljunggren, Malmberg: "DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells." in: Cancer research, Vol. 67, Issue 3, pp. 1317-25, 2007 (PubMed).
Tomescu, Chehimi, Maino, Montaner: "NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 179, Issue 4, pp. 2097-104, 2007 (PubMed).
Marcenaro, Gallo, Martini, Santoro, Griffiths, Aricó, Moretta, Pende: "Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease." in: Blood, Vol. 108, Issue 7, pp. 2316-23, 2006 (PubMed).
Deetz, Hebbeler, Propp, Cairo, Tikhonov, Pauza: "Gamma interferon secretion by human Vgamma2Vdelta2 T cells after stimulation with antibody against the T-cell receptor plus the Toll-Like receptor 2 agonist Pam3Cys." in: Infection and immunity, Vol. 74, Issue 8, pp. 4505-11, 2006 (PubMed).
Furuta, Ikeda, Nakayama, Nakamura, Tanaka, Hamasaki, Himeno, Hamilton, August: "Expression of lysosome-associated membrane proteins in human colorectal neoplasms and inflammatory diseases." in: The American journal of pathology, Vol. 159, Issue 2, pp. 449-55, 2001 (PubMed).
Mane, Marzella, Bainton, Holt, Cha, Hildreth, August: "Purification and characterization of human lysosomal membrane glycoproteins." in: Archives of biochemistry and biophysics, Vol. 268, Issue 1, pp. 360-78, 1989 (PubMed).
- Majer, Vlaskova, Krol, Kalina, Kubanek, Stolnaya, Dvorakova, Elleder, Sikora: "Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency." in: Gene, Vol. 498, Issue 2, pp. 183-95, 2012 (PubMed).
- Alternative Name
- CD107a (LAMP1 Antibody Abstract)
- CD107a, LAMPA, LGP120, AI196048, Lamp-1, LEP100, LAMP-1, LGP-A, Lgpa, Lysosome-associated membrane protein 1, cd107a, lamp-1, lamp1, lampa, lgp120, rexp76, lysosomal associated membrane protein 1, lysosomal-associated membrane protein 1, lysosomal-associated membrane protein 1 L homeolog, LAMP1, Lamp1, lamp1.L
- CD107a (lysosome-associated membrane protein-1, LAMP-1), together with LAMP-2, is a major constituent of lysosomal membrane, 1-2 % of total CD107a is found also on the plasma membrane. The LAMP proteins are involved in lysosome biogenesis and are required for fusion of lysosomes with phagosomes. Increased CD107a immunoreactivity is observed in neurones, and in glial cells surrounding senile plaques in Alzheimers disease cases and is localized mainly in medullary epithelial cells, single macrophages and lymphocytes in acute thymic involution. CD107a is a good marker of mast cell activation.
- Gene ID